Intratumor KRAS mutation heterogeneity and inhomogeneous distribution over the tumor tissue were observed in colorectal cancer (Kosmidou et al. 2014) and prostate cancer (Konishi et al. 1995). This evidence concerns the gene KRAS and colorectal cancer.